Evidence map›Paper›PMID 41462077›Full record

ArticleBMC bioinformatics2025

Prodigy protein: Python package for zero-shot protein engineering using protein language models.

Matthew Massett, Adrian Carr

Abstract read
In one paragraph

Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A p53Molecular therapy. Oncology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Matthew MassettAI Innovation, Sanofi, Babraham Research Campus, Cambridge, CB22 3AT, UK. matthew.massett@sanofi.com.
Adrian CarrAI Innovation, Sanofi, Babraham Research Campus, Cambridge, CB22 3AT, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProtein Language Models (PLMs) are emerging as powerful tools for designing human proteins, including antibodies. These models can predict the effects of mutations in a zero-shot setting-without requiring additional fine-tuning-and suggest plausible amino acid substitutions.

resultsWe introduce Protein Diversification and Generation through Yielded Mutations (Prodigy) Protein which provides several DirectedEvolution classes that introduce amino acid substitutions in a stepwise manner. Each substitution is evaluated using one of two scoring strategies, and the most promising candidates are sampled accordingly. Users can customize the number of evolution steps, specify target regions within the protein sequence, and set score thresholds to filter out low-quality substitutions during the design process.

conclusionProtein Diversification and Generation through Yielded Mutations (Prodigy) Protein is a fast and flexible tool for in silico protein design. It introduces a consistent and efficient probabilistic framework that leverages any masked language modeling Protein Language Model (PLM) available via Hugging Face. Unlike existing tools, Prodigy Protein can integrate multiple PLMs to design protein variants-an approach not currently supported by other publicly available software.

Indexed as

Protein EngineeringProteinsSoftwareAmino Acid SubstitutionHumansMutationProgramming LanguagesProteinsDirected evolutionProtein designProtein Language ModelSequence optimisation

Identifiers

PMID41462077
PMCPMC12751917

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.